Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    USAMRIID Seeks Animal Vaccination Services for Immunogenicity Studies

    By Global Biodefense StaffMarch 31, 2014
    Share
    Facebook LinkedIn Reddit Email

    The Virology Division at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Md. has a requirement to evaluate the immunogenicity of a novel vaccine platform administered in multiple formulations (28 or 56 days apart) by intramuscular injection to Cynomolgus macaques.

    The vendor must be capable of pre-screening all animals and confirm they are negative for the following pathogens: Filoviruses, Alphaviruses, tuberculosis, HMV phenotype of Klebsiella pneumoniae, shigella, salmonella, and Yersinia. The vendor must be able to collect whole blood in serum separator (SST), EDTA K2, Na citrate, and CPT Heparin collection tubes at various time points both pre- and post-vaccination of the animals.

    After blood collection, the vendor must be able to process each sample and aliquot accordingly for serum (SST), whole blood (EDTA K2), plasma (Na Citrate), and PBMCs (CPT Heparin) and ship the samples to USAMRIID for additional analysis. If during USAMRIID analysis, it is determined that the animals produced an adequate immune response to the vaccine, the vendor will ship the animals to USAMRIID for additional evaluation; if the animals do not produce an adequate response to the vaccine, then the vendor will dispose of the animals according to their own institute policies and procedures.

    Further details are available under Solicitation Number: Solicitation Number: W81XWH-14-T-0112. The response deadline is April 14, 2014.

    Shigella USAMRIID Vaccine News Y. pestis
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – March 30, 2014
    Next Article Ebola Virus Now Confirmed in Liberia

    Related Stories

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Human BCG Challenge Model for Assessment of Tuberculosis Immunity

    December 2, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    Black Death Impact on Microbiome May Have Contributed to Modern-Day Chronic Diseases

    November 29, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.